Boothbay Fund Management, LLC Oramed Pharmaceuticals Inc. Transaction History
Boothbay Fund Management, LLC
- $4.45 Billion
- Q2 2025
A detailed history of Boothbay Fund Management, LLC transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 845,391 shares of ORMP stock, worth $1.78 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
845,391
Previous 845,488
0.01%
Holding current value
$1.78 Million
Previous $1.81 Million
5.14%
% of portfolio
0.04%
Previous 0.06%
Shares
10 transactions
Others Institutions Holding ORMP
# of Institutions
56Shares Held
7.7MCall Options Held
46.2KPut Options Held
0-
Bml Capital Management, LLC Zionsville, IN3.08MShares$6.47 Million5.25% of portfolio
-
Murchinson Ltd. Toronto, A61.75MShares$3.68 Million1.73% of portfolio
-
Morgan Jess S & CO Inc366KShares$769,4422.07% of portfolio
-
Rathbones Group PLC Liverpool, X0233KShares$489,3370.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX167KShares$350,4870.0% of portfolio
About ORAMED PHARMACEUTICALS INC.
- Ticker ORMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,100
- Market Cap $81.5M
- Description
- Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...